BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26748426)

  • 1. PRODIGE 34-FFCD 1402-ADAGE: Adjuvant chemotherapy in elderly patients with resected stage III colon cancer: A randomized phase 3 trial.
    Aparicio T; Francois E; Cristol-Dalstein L; Carola E; Maillard E; Paillaud E; Retornaz F; Faroux R; André T; Bedenne L; Seitz JF
    Dig Liver Dis; 2016 Feb; 48(2):206-7. PubMed ID: 26748426
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients.
    Schmoll HJ; Cartwright T; Tabernero J; Nowacki MP; Figer A; Maroun J; Price T; Lim R; Van Cutsem E; Park YS; McKendrick J; Topham C; Soler-Gonzalez G; de Braud F; Hill M; Sirzén F; Haller DG
    J Clin Oncol; 2007 Jan; 25(1):102-9. PubMed ID: 17194911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in research on capecitabine as adjuvant treatment for colon cancer after radical resection].
    Zhang SZ
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):801-3. PubMed ID: 21223682
    [No Abstract]   [Full Text] [Related]  

  • 4. Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.
    Schmoll HJ; Tabernero J; Maroun J; de Braud F; Price T; Van Cutsem E; Hill M; Hoersch S; Rittweger K; Haller DG
    J Clin Oncol; 2015 Nov; 33(32):3733-40. PubMed ID: 26324362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands.
    van Gils CW; Koopman M; Mol L; Redekop WK; Uyl-de Groot CA; Punt CJ
    Acta Oncol; 2012 Jan; 51(1):57-64. PubMed ID: 22122695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redefining adjuvant chemotherapy in patients with stage III colon cancer: X-ACT trial.
    Glen H; Cassidy J
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):547-51. PubMed ID: 18402521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of single agent or combination adjuvant chemotherapy in elderly patients with colon cancer: a Canadian cancer institute experience.
    Kim CA; Spratlin JL; Armstrong DE; Ghosh S; Mulder KE
    Clin Colorectal Cancer; 2014 Sep; 13(3):199-206. PubMed ID: 25088184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy of colon cancer: lymph node involvement without metastases.
    Prescrire Int; 2006 Jun; 15(83):109-1. PubMed ID: 16764102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Difference of colon cancer and rectal cancer-from the view of an oncological physician].
    Xu JM
    Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):321-3. PubMed ID: 20723426
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.
    Taieb J; Tabernero J; Mini E; Subtil F; Folprecht G; Van Laethem JL; Thaler J; Bridgewater J; Petersen LN; Blons H; Collette L; Van Cutsem E; Rougier P; Salazar R; Bedenne L; Emile JF; Laurent-Puig P; Lepage C;
    Lancet Oncol; 2014 Jul; 15(8):862-73. PubMed ID: 24928083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant therapy in colon cancer: which treatment in 2005?
    Di Costanzo F; Doni L
    Ann Oncol; 2005 May; 16 Suppl 4():iv69-73. PubMed ID: 15923433
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of mFOLFOX6/XELOX as adjuvant chemotherapy after curative resection of stage III colon cancer: phase II clinical study (The FACOS study).
    Kosugi C; Koda K; Ishibashi K; Yoshimatsu K; Tanaka S; Kato R; Kato H; Oya M; Narushima K; Mori M; Shuto K; Ishida H
    Int J Colorectal Dis; 2018 Jun; 33(6):809-817. PubMed ID: 29484450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial].
    Kubicka S
    Strahlenther Onkol; 2016 Jul; 192(7):505-6. PubMed ID: 27272658
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study.
    Baretti M; Rimassa L; Personeni N; Giordano L; Tronconi MC; Pressiani T; Bozzarelli S; Santoro A
    Clin Colorectal Cancer; 2018 Sep; 17(3):e489-e498. PubMed ID: 29650416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy for stage II and III colorectal cancer.
    de Gramont A; Tournigand C; André T; Larsen AK; Louvet C
    Semin Oncol; 2007 Apr; 34(2 Suppl 1):S37-40. PubMed ID: 17449351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of adjuvant capecitabine compared with bolus 5-fluorouracil/leucovorin regimen in dukes C colon cancer: results from the X-ACT trial.
    Reddy GK
    Clin Colorectal Cancer; 2004 Jul; 4(2):87-8. PubMed ID: 15285814
    [No Abstract]   [Full Text] [Related]  

  • 17. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea.
    Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH
    Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer.
    Lamberti C; Sauerbruch T; Glasmacher A
    Cancer Treat Rev; 2005 Dec; 31(8):648-52. PubMed ID: 16289340
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacoeconomic analysis of capecitabine versus 5-fluorouracil/leucovorin as adjuvant therapy for stage III colon cancer in Taiwan.
    Hsu TC; Chen HH; Yang MC; Wang HM; Chuang JH; Jao SW; Chiang HC; Wen CY; Tseng JH; Chen LT
    Value Health; 2011; 14(5):647-51. PubMed ID: 21839401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Adjuvant FOLFOX Chemotherapy Duration on Outcomes of Patients With Stage III Colon Cancer.
    Kumar A; Peixoto RD; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Speers CH; Cheung WY
    Clin Colorectal Cancer; 2015 Dec; 14(4):262-8.e1. PubMed ID: 26123496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.